-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Atidarsagene Autotemcel in Metachromatic Leukodystrophy (MLD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Atidarsagene Autotemcel in Metachromatic Leukodystrophy (MLD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atidarsagene Autotemcel in Metachromatic Leukodystrophy (MLD) Drug Details: Atidarsagene autotemcel...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OTL-203 in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OTL-203 in Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OTL-203 in Mucopolysaccharidosis I (MPS I) (Hurler...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Exagamglogene Autotemcel in Beta Thalassaemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Exagamglogene Autotemcel in Beta Thalassaemia Drug Details: Exagamglogene autotemcel (Casgevy) is a genetically modified autologous...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MWPC-005 in Basal Cell Carcinoma (Basal Cell Epithelioma)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MWPC-005 in Basal Cell Carcinoma (Basal Cell Epithelioma) Drug Details: MWPC-005 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – M-ceNK in Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. M-ceNK in Non-Small Cell Lung Cancer Drug Details: Cellular Immunotherapy is under development for the...
-
Product Insights
Mandrup – Solar PV Park
Mandrup - Solar PV Park is a solar PV project located in Maharashtra, India. The project is owned and developed by Enrich Energy Pvt Ltd. The project is currently active. Empower your strategies with our Mandrup - Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
D.J.Malpani Solar PV Park
D.J.Malpani Solar PV Park is a solar PV project located in Telangana, India. The project is owned by D.J.Malpani and was developed by Enrich Energy Pvt Ltd. The project came online in 2015. Empower your strategies with our D.J.Malpani Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nemvaleukin Alfa in Recurrent Head And Neck Cancer Squamous Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nemvaleukin Alfa in Recurrent Head And Neck Cancer Squamous Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nemvaleukin Alfa in Recurrent Head...